首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2418895篇
  免费   201592篇
  国内免费   4472篇
耳鼻咽喉   34784篇
儿科学   74011篇
妇产科学   64253篇
基础医学   340754篇
口腔科学   68827篇
临床医学   220335篇
内科学   478909篇
皮肤病学   48572篇
神经病学   204383篇
特种医学   97401篇
外国民族医学   888篇
外科学   367457篇
综合类   57029篇
现状与发展   2篇
一般理论   1021篇
预防医学   194838篇
眼科学   56884篇
药学   180856篇
  4篇
中国医学   4473篇
肿瘤学   129278篇
  2018年   25149篇
  2017年   19407篇
  2016年   21314篇
  2015年   24157篇
  2014年   34900篇
  2013年   53059篇
  2012年   71589篇
  2011年   75440篇
  2010年   44311篇
  2009年   42601篇
  2008年   71824篇
  2007年   76315篇
  2006年   77091篇
  2005年   75215篇
  2004年   72308篇
  2003年   69581篇
  2002年   68832篇
  2001年   112912篇
  2000年   116902篇
  1999年   98803篇
  1998年   28427篇
  1997年   25949篇
  1996年   25801篇
  1995年   24972篇
  1994年   23493篇
  1993年   21868篇
  1992年   79742篇
  1991年   76709篇
  1990年   73833篇
  1989年   71115篇
  1988年   66101篇
  1987年   65051篇
  1986年   61550篇
  1985年   58672篇
  1984年   44534篇
  1983年   37938篇
  1982年   23306篇
  1981年   20666篇
  1980年   19402篇
  1979年   41517篇
  1978年   29220篇
  1977年   24581篇
  1976年   23027篇
  1975年   24173篇
  1974年   29811篇
  1973年   28202篇
  1972年   26357篇
  1971年   24222篇
  1970年   22857篇
  1969年   21159篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
42.
43.
44.
45.
46.
47.
48.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
49.
50.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号